Score Overview
Explore the 2021 public Archive ranking →
Mednax Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 1.73B to $ 1.91B and net income went from -$ 796M to $ 165M. Revenue increased in 4 of those 5 years; net income in 2.
Across Mednax Inc's full reported history, from 1995 to 2025, revenue grew from $ 43M to $ 1.91B and net income grew from $ 6M to $ 165M. Revenue increased in 90% of the years measured; net income in 68%.
Mednax Inc currently holds a 20-year HDB Score of 4.2 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-01 | $ 26.47 | — |
1 Year2025-08-29 | $ 17.21 | 53.81% |
5 Years2021-09-01 | $ 31.52 | -16.02% |
10 Years2016-09-01 | $ 64.48 | -58.95% |
20 Years2006-09-01 | $ 22.75 | 16.33% |
30 Years1996-08-30 | $ 11.25 | 135.29% |
| Period | Last Price2026-09-01 | 1 Year2025-08-29 | 5 Years2021-09-01 | 10 Years2016-09-01 | 20 Years2006-09-01 | 30 Years1996-08-30 |
|---|---|---|---|---|---|---|
| Price | $ 26.47 | $ 17.21 | $ 31.52 | $ 64.48 | $ 22.75 | $ 11.25 |
| Return | — | 53.81% | -16.02% | -58.95% | 16.33% | 135.29% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 1.95B | $ 174M | $ 404M |
| 2025 | $ 1.91B | $ 165M | $ 499M |
| 2024 | $ 2.01B | -$ 99M | $ 348M |
| 2023 | $ 1.99B | -$ 60M | $ 177M |
| 2022 | $ 1.97B | $ 66M | $ 103M |
| 2021 | $ 1.91B | $ 130M | $ 487M |
| 2020 | $ 1.73B | -$ 796M | $ 1.22B |
| 2019 | $ 1.77B | -$ 1.49B | $ 182M |
| 2018 | $ 3.64B | $ 268M | $ 58M |
| 2017 | $ 3.45B | $ 320M | $ 70M |
| 2016 | $ 3.18B | $ 324M | $ 66M |
| 2015 | $ 2.77B | $ 336M | $ 60M |
| 2014 | $ 2.43B | $ 317M | $ 53M |
| 2013 | $ 2.15B | $ 280M | $ 37M |
| 2012 | $ 1.81B | $ 240M | $ 27M |
| 2011 | $ 1.58B | $ 217M | $ 22M |
| 2010 | $ 1.40B | $ 202M | $ 43M |
| 2009 | $ 1.28B | $ 175M | $ 31M |
| 2008 | $ 1.06B | $ 169M | $ 35M |
| 2007 | $ 917M | $ 142M | $ 120M |
| 2006 | $ 818M | $ 124M | |
| 2005 | $ 693M | $ 89M | $ 22M |
| 2004 | $ 619M | $ 98M | $ 16M |
| 2003 | $ 551M | $ 84M | $ 27M |
| 2002 | $ 465M | $ 68M | $ 73M |
| 2001 | $ 354M | $ 30M | $ 27M |
| 2000 | $ 243M | $ 10M | $ 3M |
| 1999 | $ 227M | $ 25M | $ 800K |
| 1998 | $ 185M | $ 29M | $ 700K |
| 1997 | $ 128M | $ 20M | $ 18M |
| 1996 | $ 80M | $ 13M | $ 18M |
| IPO1995 | $ 43M | $ 6M | $ 18M |
Where Mednax Inc has ranked, year by year
Each point is that year's ranking on ten years of fundamentals, as a share of every company we could rank at the time. Higher is better. We show the share rather than the place because the number of companies grows — 989 in 2006, 2,060 in 2021 — so the same place means something different at either end.
Reached the top 50 on HDB Score in 7 years, the longest run being 7 in a row — but not in 2021.
2006: 14.8% · 2021: 76.0% · free through 2021 · longest runs
See where MD ranks today
You're looking at Mednax Inc's public company record. Membership adds the current comparative layer and continues its ranking history through recent years.
- Current market-wide rankings across 3,839 covered companies
- See where Mednax Inc ranks today
- Complete current Score Views across every period
- Current Tenure and recent Archive years
- Portfolio and member features
$99/year $149 founding price
Become a Member30-day money-back guarantee.
